Educational Video for Cancer Clinical Trials
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if an educational video can enhance understanding and interest in cancer clinical trials. The video will address topics such as the importance of clinical trials, common myths, and ways to find more information. It targets individuals in the Detroit area who are receiving treatment at the Karmanos Cancer Institute or attend their community events. This trial suits anyone interested in learning more about cancer clinical trials and willing to provide informed consent. As an unphased study, this trial offers a unique opportunity to increase knowledge and engagement with cancer clinical trials.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this educational intervention is safe?
Research has shown that educational videos, like the one used in this trial, are generally safe and easy for people to handle. In previous studies with similar videos, no negative effects were reported. For instance, one study used an 18-minute educational video with breast cancer patients and found it improved their understanding without any safety issues. Another study found that videos enhanced patients' attitudes and knowledge about clinical trials without causing harm.
Overall, incorporating an educational video into the treatment is considered safe and poses no known risks for participants.12345Why are researchers excited about this trial?
Researchers are excited about the web-based educational intervention for cancer clinical trials because it aims to demystify the clinical trial process for patients. Unlike traditional patient education methods, which often involve one-on-one discussions with healthcare providers, this approach uses an engaging video format to address common myths and provide clear information on the purpose and benefits of participating in clinical trials. By making information more accessible and understandable, this intervention could potentially increase patient participation in clinical trials, helping advance cancer research and improving outcomes.
What evidence suggests that this educational video is effective for increasing knowledge and interest in cancer clinical trials?
Research has shown that online educational tools can enhance understanding and foster a more positive attitude toward clinical trials. For example, one study found that a short video program increased willingness to join clinical trials. Another study discovered that a web-based education program helped cancer patients manage symptoms and improve quality of life. Additionally, an online program for cancer nurses boosted their knowledge and increased their likelihood of discussing clinical trials with patients. This trial will test a web-based educational intervention, where participants will view an educational video about cancer clinical trials. These findings suggest that using a video to teach about cancer clinical trials could effectively increase understanding and interest in participation.678910
Who Is on the Research Team?
Hayley Thompson
Principal Investigator
Barbara Ann Karmanos Cancer Institute
Are You a Good Fit for This Trial?
This trial is for individuals in the Detroit area served by the Karmanos Cancer Institute who have cancer or blood tumors. It aims to educate them about clinical trials.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Educational Intervention
Participants view an educational video on the purpose of clinical trials, myths, and how to find more information
Follow-up
Participants are monitored for changes in knowledge and intention to participate in clinical trials
What Are the Treatments Tested in This Trial?
Interventions
- Web-based Educational Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hayley Thompson
Lead Sponsor
National Cancer Institute (NCI)
Collaborator